« Previous
Next »
Seminars in Perinatology
Volume 32, Issue 3
, Pages 201-205
, June 2008
The Fetal Response to Chronic Placental Insufficiency
References
- Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics. 1963;32:793–800
- . Problems of the small-for-dates baby. Clin Obstet Gynaecol. 1984;11:499–524
- . The value of antenatal fetal monitoring. Progr Obstet Gynaecol. 1981;1:105–124
- . Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J (Clin Res Ed). 1987;294:1051–1053
- . Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1989;161:996–1001
- Cord sampling for the evaluation of oxygenation and acid-base balance in growth-retarded human fetuses. Am J Obstet Gynecol. 1987;157:1221–1228
- . Doppler measurements of fetal and uteroplacental circulations: relationship with umbilical venous blood gases measured at cordocentesis. Am J Obstet Gynecol. 1990;162:115–120
- . The relationship between the umbilical artery systolic/diastolic ratio and umbilical blood gas measurements in specimens obtained by cordocentesis. Am J Obstet Gynecol. 1990;162:1198–1202
- Abnormal velocity waveforms of the umbilical artery in growth retarded fetuses: relationship to antepartum late heart rate decelerations and outcome. Early Hum Dev. 1990;24:79–89
- Diagnostic value of blood sampling in fetuses with growth retardation. N Engl J Med. 1993;328:692–696
- Fetal biophysical profile score (VI. Correlation with antepartum umbilical venous fetal pH). Am J Obstet Gynecol. 1993;169:755–763
- Relationship between the fetal biophysical profile score, umbilical artery Doppler velocimetry, and fetal blood acid-base status determined by cordocentesis. Am J Obstet Gynecol. 1993;169:1586–1594
- . Inferior vena cava flow velocity waveforms in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1992;166:1271–1280
- Fetal venous, intracardiac, and arterial blood flow measurements in intrauterine growth retardation: relationship with fetal blood gases. Am J Obstet Gynecol. 1995;173:10–15
- Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol. 2001;18:564–570
- Maternal oxygen therapy for intrauterine growth retardation. Lancet. 1987;1:942–945
- Maternal hyperoxygenation in the treatment of intrauterine growth retardation. Am J Obstet Gynecol. 1992;167:430–435
- A prospective randomised comparison of the effect of continuous O2 therapy and bedrest on fetuses with absent end-diastolic flow on umbilical artery Doppler waveform analysis. Br J Obstet Gynaecol. 1995;102:662–665
- A double-blind randomised controlled trial of continuous oxygen therapy for compromised fetuses. Br J Obstet Gynaecol. 2002;109:509–513
- . Maternal oxygen administration for suspected impaired fetal growth. Cochrane Database Syst Rev. 2003;CD000137
- . Neonatal nucleated red blood cell counts in small-for-gestational age fetuses with abnormal umbilical artery Doppler studies. Am J Obstet Gynecol. 1997;177:1079–1084
- . Evaluation of severe growth retardation using cordocentesis: hematologic and metabolic alterations by etiology. Obstet Gynecol. 1989;73:225–229
- . Serum ferritin and cobalamin in growth retarded fetuses. Br J Obstet Gynaecol. 1994;101:215–219
- Indicators of platelet turnover in thrombocytopenic infants. Br J Obstet Gynaecol. 1997;104:743–745
- . Platelet count in normal, small, and anemic fetuses. Am J Obstet Gynecol. 1990;162:735–739
- . Fetal platelet consumption: a feature of placental insufficiency. Obstet Gynecol. 1991;77:616–621
- Umbilical amino acid uptake at increasing maternal amino acid concentrations: effect of a maternal amino acid infusate. Am J Obstet Gynecol. 1999;181:477–483
- Tissue concentrations of free amino acids in term human placentas. Am J Obstet Gynecol. 1978;131:881–887
- . The uptake of naturally occurring amino acids by the plasma membrane of the human placenta. Placenta. 1982;3:13–20
- Maternal concentrations and fetal-maternal concentration differences of plasma amino acids in normal and intrauterine growth-restricted pregnancies. Am J Obstet Gynecol. 1996;174:1575–1583
- Umbilical amino acid concentrations in appropriate and small for gestational age infants: a biochemical difference present in utero. Am J Obstet Gynecol. 1988;158:120–126
- Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. Am J Obstet Gynecol. 1990;162:253–261
- Plasma amino acids in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1989;161:1219–1227
- Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab. 2001;86:5427–5432
- Amino acid (system A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies. Pediatr Res. 1993;34:661–665
- Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatr Res. 1997;42:514–519
- . Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr Res. 1998;44:532–537
- Steady state maternal-fetal leucine enrichments in normal and intrauterine growth-restricted pregnancies. Pediatr Res. 1999;46:114–119
- . The free aminoacids of plasma and urine in kwashiorkor. Lancet. 1960;1:615–618
- . Increased gluconeogenic substrates in the small-for-gestational-age infant. N Engl J Med. 1974;291:322–328
- . Amniotic fluid glycine/valine ratio is elevated in fetuses with growth retardation. J Matern Fetal Med. 1994;3:251–254
- Amniotic fluid glycine-valine ratio and neonatal morbidity in fetal growth restriction. Obstet Gynecol. 1997;90:933–937
- An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies. Metabolism. 1993;42:860–864
- . Glucose transporters in the human placenta. Placenta. 2000;21:14–22
- . Plasma insulin in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1989;160:1091–1094
- . Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab. 1993;77:1554–1562
- Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by alloimmunization and fetal growth retardation. Am J Obstet Gynecol. 1989;161:924–927
- The impact of gestational age and fetal growth on the maternal-fetal glucose concentration difference. Obstet Gynecol. 1996;87:937–942
- Effects of fetal intravenous glucose challenge in normal and growth retarded fetuses. Horm Metab Res. 1990;22:426–430
- . The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth. J Endocrinol. 1992;132:11–19
- Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinol (Copenh). 1985;110:558–563
- Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses. J Endocrinol Invest. 1995;18:346–353
- Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus (Relationships with growth in normal subjects and in subjects with intrauterine growth retardation). Pediatr Res. 1991;29:219–225
- Growth factors and intrauterine growth retardation (I. Serum growth hormone, insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein 3 levels in normally grown and growth-retarded human fetuses during the second half of gestation). Pediatr Res. 1996;40:94–100
- Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab. 2000;85:4298–4301
- Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term. Pediatr Res. 2000;48:646–651
- Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol. 1994;21:737–748
- . Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat. Am J Obstet Gynecol. 1997;176:73–76
- . Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats. J Soc Gynecol Invest. 2001;8:18–23
- . Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. Am J Obstet Gynecol. 2006;194:1377–1383
- Endothelin-1,2 levels in umbilical vein serum of intra-uterine growth retarded fetuses as detected by cordocentesis. Acta Obstet Gynecol Scand. 1994;73:21–24
- Maternal and fetal plasma endothelin levels in intrauterine growth restriction: relation to umbilical artery Doppler flow velocimetry. J Perinat Med. 2003;31:52–59
- Catecholamine levels and their correlation to blood gases in umbilical venous blood obtained by cordocentesis. Fetal Diagn Ther. 1990;5:147–152
- Plasma adenosine concentration in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1994;170:684–688
PII: S0146-0005(07)00136-X
doi: 10.1053/j.semperi.2007.11.002
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Perinatology
Volume 32, Issue 3
, Pages 201-205
, June 2008
